TAVR for aortic valve regurgitation: Ready for a randomized trial?
- PMID: 30719856
- DOI: 10.1002/ccd.28079
TAVR for aortic valve regurgitation: Ready for a randomized trial?
Abstract
Transcatheter aortic valve replacement has been used successfully to treat native aortic valve regurgitation. Current observational evidence shows promising results in terms of procedural success while outcome data are difficult to interpret given the observational nature of the evidence. We are ready for a randomized trial, which will be very challenging to run.
© 2019 Wiley Periodicals, Inc.
Comment on
-
Safety and efficacy of transcatheter aortic valve replacement for native aortic valve regurgitation: A systematic review and meta-analysis.Catheter Cardiovasc Interv. 2019 Feb 1;93(2):345-353. doi: 10.1002/ccd.27840. Epub 2018 Sep 30. Catheter Cardiovasc Interv. 2019. PMID: 30269437
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
